References
- Frank PI, Frank TL, Cropper J, et al. The use of a screening questionnaire to identify children with likely asthma. Br J Gen Prac 2001; 51: 117–120
- Floyer J. A treatise of the asthma 1698 (p. 74).
- Hansen K. Uber schimmelpilz-asthma. Verhandl Deutsch Gesellsch Inn Med 1928; 40: 204
- Cohen MB, Cohen S, Hawver K. Further observations on the nature of the house dust antigen. J Allergy 1939; 10: 561–565
- Zureik M, Neukirch C, Leynaert B, et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. Br Med J 2002; 325: 411–415
- O'Driscoll RB, Hopkinson L. Mould allergy is common in patients with severe asthma. Am Rev Respir Dis 1998; 157: A623
- Langley SJ, Goldthorpe G, Truman N, Woodcock A, Custovic A. Impaired lung function in asthma is associated with sensitization to airborne moulds. Am J Respir Crit Car Med 2004; 169: A309
- Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma – a summary of the evidence. Eur Resp J 2006; in press.
- Dales RE, Cakmak S, Judek S, et al. The role of fungal spores in thunderstorm asthma. Chest 2003; 123: 745–750
- Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 11: 756–762
- Wark PA, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111: 952–957
- Riding DM, Denning D, Francis HC, Niven RMCL. The effect of itraconazole therapy in severe asthma patients allergic to aspergillus: a retrospective audit. [Abstr 75] Advances against aspergillosis, 9–11 September, 2004, San Francisco.